Yeomans Consulting Group Inc. Purchases New Shares in Axon Enterprise, Inc $AXON

Key Points

• Yeomans Consulting Group Inc. has acquired 870 shares of Axon Enterprise, Inc., worth approximately $675,000, during the second quarter.
• In recent insider transactions, President Joshua Isner and CEO Patrick W. Smith sold shares totaling over $19 million, which reflects a decrease in their ownership stakes.
• Axon Enterprise reported a 32.6% increase in quarterly revenue year-over-year, with earnings per share of $2.12, surpassing analysts' estimates of $1.54.

Yeomans Consulting Group Inc. purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 870 shares of the biotechnology company's stock, valued at approximately $675,000.

A number of other institutional investors have also recently bought and sold shares of the business. LaSalle St. Investment Advisors LLC increased its holdings in shares of Axon Enterprise by 2.1% during the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company's stock worth $408,000 after purchasing an additional 16 shares during the period. Smartleaf Asset Management LLC grew its position in Axon Enterprise by 5.0% during the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company's stock worth $203,000 after buying an additional 18 shares in the last quarter. Pinion Investment Advisors LLC grew its position in Axon Enterprise by 3.0% during the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock worth $341,000 after buying an additional 19 shares in the last quarter. Kentucky Retirement Systems increased its stake in Axon Enterprise by 0.4% during the 1st quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock worth $2,605,000 after acquiring an additional 19 shares during the period. Finally, WCM Investment Management LLC raised its holdings in Axon Enterprise by 0.8% in the 1st quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock valued at $1,306,000 after acquiring an additional 19 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the company's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the transaction, the president owned 238,379 shares of the company's stock, valued at $177,892,712.54. This represents a 6.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $743.64, for a total value of $7,436,400.00. Following the completion of the transaction, the chief executive officer owned 3,043,982 shares of the company's stock, valued at $2,263,626,774.48. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 49,932 shares of company stock worth $37,978,216 over the last three months. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

AXON stock opened at $720.53 on Friday. The stock has a market cap of $56.56 billion, a price-to-earnings ratio of 177.91, a P/E/G ratio of 27.62 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The company has a 50 day simple moving average of $758.18 and a 200 day simple moving average of $706.15. Axon Enterprise, Inc has a 1 year low of $403.16 and a 1 year high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company's quarterly revenue was up 32.6% on a year-over-year basis. During the same quarter last year, the business posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on AXON. JPMorgan Chase & Co. increased their target price on Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a report on Thursday, July 17th. Piper Sandler assumed coverage on shares of Axon Enterprise in a research report on Tuesday, September 23rd. They set an "overweight" rating and a $893.00 price objective for the company. Needham & Company LLC reissued a "buy" rating and issued a $870.00 target price on shares of Axon Enterprise in a report on Wednesday, September 24th. Raymond James Financial restated an "outperform" rating and issued a $855.00 target price (up from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the stock an "overweight" rating in a research report on Friday, July 11th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.